Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

5:00 PM ET 8-K/A
M&A Deal Blue Owl Real Estate Net Lease Trust ORENT

Blue Owl Real Estate Net Lease Trust Signs $2.45B M&A Deal with Sila Realty Trust, Inc.

Blue Owl Real Estate Net Lease Trust completed the acquisition of Sila Realty Trust, Inc. on July 1, 2026, for total consideration of approximately $2,452.7 million. The transaction involved the acquisition of Sila's portfolio of net-leased healthcare real estate properties for $30.38 per share in cash. This filing (Form 8-K/A) provides the required audited financial statements and pro forma financial information related to the completed merger.

Value
$2.45B
Counterparty
Sila Realty Trust, Inc.
4:49 PM ET 8-K/A
M&A Deal Presidio Production Co FTW

Presidio Production M&A Deal with Canyon Creek Energy – Arkoma, LLC

Presidio Production Company filed an amendment to provide required financial statements and pro forma information regarding its completed acquisition of oil and gas properties in the Arkoma Basin. The assets were acquired from several entities including Canyon Creek Energy, Alchemist Energy, and Pivotal Arkoma Basin II. The acquisition closed in stages on July 1 and July 21, 2026.

Counterparty
Canyon Creek Energy – Arkoma, LLC
4:46 PM ET 8-K
M&A Deal NewHold Investment Corp. III NHICU

NewHold Investment Corp. III M&A Deal with newcleo plc

Shareholders of NewHold Investment Corp. III approved the company's business combination with newcleo plc, an innovative nuclear energy company developing advanced modular reactors. The transaction is expected to close on September 21, 2026, after which the combined company will trade on Nasdaq under the symbols 'NWCL' and 'NWCLW'.

Counterparty
newcleo plc
4:40 PM ET 8-K
Contract Win Centrus Energy Corp LEU

Centrus Energy Wins Contract from Antares Nuclear

Centrus Energy signed a definitive multi-year contract to supply High-Assay Low-Enriched Uranium (HALEU) to Antares Nuclear for its advanced microreactor projects. The agreement includes prepayments from Antares to support Centrus' expansion of domestic enrichment capacity, with deliveries scheduled to begin before the end of the decade.

Counterparty
Antares Nuclear
Term
Multi-year
4:38 PM ET 8-K
M&A Deal AES Corp AES

AES M&A Deal with Horizon Parent, L.P.

The AES Corporation received approval from the Public Utilities Commission of Ohio for its pending merger with Horizon Parent, L.P., an entity affiliated with Global Infrastructure Management and EQT Infrastructure. The regulatory approval is a key condition for the closing of the transaction, which will result in AES being taken private. The merger remains subject to additional regulatory approvals and customary closing conditions.

Counterparty
Horizon Parent, L.P.
4:36 PM ET 8-K
Nasdaq/NYSE Compliance Notice Hub Group, Inc. HUBG

Hub Group Nasdaq/NYSE Compliance Notice

Hub Group received a Staff Delisting Determination from Nasdaq on September 16, 2026, due to the company's failure to timely file its 2025 Annual Report and subsequent 2026 Quarterly Reports. The company intends to appeal the determination and request a hearing before the Nasdaq Hearings Panel to present a plan to regain compliance and stay the delisting process.

Counterparty
Nasdaq
4:31 PM ET 8-K
Licensing Deal Interparfums Inc IPAR

Interparfums Licensing Deal with Marquee Brands

Interparfums and Marquee Brands have signed a 20-year extension of their exclusive worldwide license agreement for Roberto Cavalli and Just Cavalli fragrances, extending the partnership through December 31, 2046. The deal covers the continued creation, development, and distribution of fragrances globally following the successful 2025 launch of the Serpentine blockbuster fragrance.

Counterparty
Marquee Brands
Term
20 years (through 2046)
4:31 PM ET 8-K
M&A Deal Watsco Inc WSO

Watsco Signs $505M M&A Deal with Granite Group Holdings LLC

Watsco, Inc. has entered into a definitive agreement to acquire Granite Group Holdings LLC, a Northeast distributor of plumbing and HVAC products with approximately $500 million in annual sales. The total purchase price is $505 million, to be paid as 80% cash and 20% in Watsco common stock. The deal is subject to customary closing conditions, including Hart-Scott-Rodino antitrust clearance.

Value
$505M
Counterparty
Granite Group Holdings LLC
4:30 PM ET 8-K
Partnership Myseum.AI, Inc. MYSE

Myseum.AI Partnership with FUJIFILM North America Corporation

Myseum.AI has entered into a strategic partnership with Fujifilm to integrate print-on-demand services into its Picture Party social platform. The collaboration allows users to order high-resolution photo prints and customizable products directly through the app, leveraging Fujifilm's printing infrastructure to create a new revenue stream for Myseum.AI.

Counterparty
FUJIFILM North America Corporation
4:25 PM ET 8-K
M&A Deal Host Digital Inc. HOST

Healthy Choice Wellness M&A Deal with Host Digital Infrastructure LLC

Healthy Choice Wellness Corp. (renamed Host Digital Inc.) completed its merger with Host Digital Infrastructure LLC, which will now operate as a wholly owned subsidiary. In connection with the closing, the company entered into registration rights agreements to facilitate the resale of shares issued as merger consideration. Host Digital Infrastructure recently secured a 15-year, $1.25 billion lease with a major cloud infrastructure provider for a 45+ megawatt data center campus in Oklahoma.

Counterparty
Host Digital Infrastructure LLC
4:22 PM ET 8-K
M&A Deal Phoenix Education Partners, Inc. PXED

Phoenix Education Partners Signs $31.5M M&A Deal with Fuel50 Inc.

Phoenix Education Partners has entered into a definitive agreement to acquire Fuel50 Inc., an AI-powered workforce transformation platform, for $31.5 million in cash. The deal includes potential earnout payments of up to $8.5 million through 2027 based on performance milestones. The acquisition aims to integrate Fuel50's workforce intelligence and talent marketplace capabilities with Phoenix Education's workforce development focus.

Value
$31.5M
Counterparty
Fuel50 Inc.
4:17 PM ET 8-K
Divestiture Rexford Industrial Realty, Inc. REXR

Rexford Industrial Realty Divestiture to EQT Real Estate for $1.2B

Rexford Industrial completed the $1.2 billion sale of a 22-property industrial portfolio to an affiliate of EQT Real Estate as part of a $2.0 billion non-core asset realignment strategy. The company intends to use the proceeds for debt repayment, common stock repurchases, and internal development projects.

Value
$1.2B
Counterparty
EQT Real Estate
4:16 PM ET 8-K
M&A Deal Armada Acquisition Corp. II XRPNU

Armada Acquisition Corp. II Signs $30M M&A Deal with Ripple Labs Inc.

Armada Acquisition Corp. II provided a status update on its pending merger with Ripple Labs Inc. and Pathfinder Digital Assets LLC, announcing that the post-combination entity (Pubco) has secured a $30 million convertible note financing from NH Investment & Securities Co. The financing is contingent upon the closing of the business combination, which is currently expected to occur in the fourth quarter of 2026.

Value
$30M
Counterparty
Ripple Labs Inc.
4:11 PM ET 8-K/A
M&A Deal Nomad Power Solutions, Inc. NMAD

Nomad Power Solutions M&A Deal with Nomad Transportable Power Systems, Inc

Nomad Power Solutions, Inc. (formerly Lixte Biotechnology Holdings, Inc.) filed an amendment to its previous 8-K to include historical and pro forma financial statements following the completion of its merger with Nomad Transportable Power Systems, Inc. The transaction resulted in NOMAD becoming a wholly-owned subsidiary of the company, which has since rebranded to Nomad Power Solutions.

Counterparty
Nomad Transportable Power Systems, Inc
4:09 PM ET 8-K
Nasdaq/NYSE Compliance Notice GoPro, Inc. GPRO

GoPro Nasdaq/NYSE Compliance Notice

GoPro, Inc. has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share. The company's Class A common stock maintained a closing bid price above the $1.00 threshold for at least ten consecutive business days, resolving the deficiency notice originally received on July 21, 2026.

Counterparty
Nasdaq
4:06 PM ET 8-K
Divestiture Axe Compute Inc. AGPU

Axe Compute Divestiture to DataMeds AI, Inc.

Axe Compute Inc. completed the sale of its legacy cancer diagnostics business, Helomics Corporation, to DataMeds AI, Inc. for 636,328 shares of DataMeds common stock and a $1.36 million convertible promissory note. The transaction marks the company's final transition into a pure-play neocloud GPU-as-a-Service provider.

Counterparty
DataMeds AI, Inc.
4:03 PM ET 8-K
Clinical Trial Data Fennec Pharmaceuticals Inc. FENC

Fennec Pharmaceuticals Clinical Trial Data

Fennec Pharmaceuticals announced positive results from the investigator-initiated Phase 2 STS-J01 clinical study of PEDMARK in Japan for pediatric and AYA patients. The study met its primary endpoint, showing hearing loss in only 24.0% of patients compared to a historical benchmark of 56.4%, while demonstrating no interference with cisplatin antitumor activity.

4:00 PM ET 8-K
Nasdaq/NYSE Compliance Notice Fifth Era Acquisition Corp I FERA

Fifth Era Acquisition Corp I Nasdaq/NYSE Compliance Notice

Fifth Era Acquisition Corp I received a deficiency notice from Nasdaq on September 14, 2026, for failing to meet the Minimum Total Holders Requirement of 400 holders. The company has until October 29, 2026, to submit a compliance plan and may be granted up to 180 days to regain compliance or transfer to the Nasdaq Capital Market.

Counterparty
Nasdaq
Term
45 days to submit plan
3:57 PM ET 8-K
Regulatory Approval Ultragenyx Pharmaceutical Inc. RARE

Ultragenyx Pharmaceutical Regulatory Approval

The FDA has granted standard full approval for Ultragenyx's FAYUVI (rebisufligene etisparvovec-hopf), the first-ever approved treatment for Sanfilippo syndrome Type A (MPS IIIA). This marks the company's second gene therapy approval and resulted in the receipt of a Priority Review Voucher.

2:04 PM ET 8-K
Partnership AB Private Lending Fund

AB Private Lending Fund Partnership with AllianceBernstein L.P.

AB Private Lending Fund's adviser terminated its sub-advisory agreement with AllianceBernstein L.P. (AB) and replaced it with a Resource Sharing Agreement. Under the new agreement, AB will provide investment professionals and facilities to assist the adviser in managing the Fund's investments in syndicated loans and bond markets.

Counterparty
AllianceBernstein L.P.
10:54 AM ET 8-K
M&A Deal American Water Works Company, Inc. AWK

American Water Works Company M&A Deal with Essential Utilities, Inc.

American Water Works and Essential Utilities filed a joint petition for a non-unanimous settlement with the Pennsylvania Public Utility Commission (PaPUC) regarding their pending merger. The settlement agreement, joined by several state consumer and investigative bureaus, represents a significant regulatory milestone toward obtaining the necessary state approvals for the acquisition. The agreement will now be reviewed by Administrative Law Judges before a final recommendation is made to the PaPUC.

Counterparty
Essential Utilities, Inc.
10:50 AM ET 8-K
M&A Deal Essential Utilities, Inc. WTRG

Essential Utilities M&A Deal with American Water Works Company, Inc.

Essential Utilities and American Water Works Company filed a joint petition for a non-unanimous settlement with the Pennsylvania Public Utility Commission (PaPUC) regarding their pending merger. The settlement agreement, joined by several state consumer and business advocates, represents a significant regulatory milestone toward obtaining the state approval required to close the transaction. The agreement will now be reviewed by Administrative Law Judges before a final recommendation is issued to the PaPUC.

Counterparty
American Water Works Company, Inc.
9:28 AM ET 8-K
M&A Deal Lisata Therapeutics, Inc. LSTA

Lisata Therapeutics M&A Deal with Marea Therapeutics, Inc.

Lisata Therapeutics acquired Marea Therapeutics in an all-stock merger, resulting in Marea becoming a wholly owned subsidiary. Concurrent with the acquisition, Lisata secured $225 million in a private placement financing to fund the development of Marea's clinical-stage cardioendocrine pipeline through 2028. Following the transactions, former Marea equityholders and new PIPE investors hold the vast majority of the combined company's equity.

Counterparty
Marea Therapeutics, Inc.
9:14 AM ET 8-K
Partnership Hive Digital Technologies Ltd. HIVE

Hive Digital Technologies Partnership with ProCogia

HIVE Digital's subsidiary BUZZ HPC entered into a strategic partnership with ProCogia to provide end-to-end sovereign AI solutions. ProCogia will procure dedicated GPU capacity from HIVE's Canadian data centers to power its AI products while serving as a preferred services partner for HIVE's clients, with both companies planning a joint go-to-market strategy in the U.S. and Europe.

Counterparty
ProCogia
9:12 AM ET 8-K
M&A Deal Caesars Entertainment, Inc. CZR

Caesars Entertainment M&A Deal with Fertitta Gaming Holdco, LLC

Caesars Entertainment provided a status update on its pending merger with Fertitta Gaming Holdco, noting that both parties received a 'Second Request' for information from the FTC, extending the HSR Act waiting period. Additionally, two board members, Jesse Lynn and Ted Papapostolou, resigned from the Board effective immediately as the Icahn Group waived its right to appoint replacements.

Counterparty
Fertitta Gaming Holdco, LLC
9:05 AM ET 8-K
Nasdaq/NYSE Compliance Notice Faraday Future Intelligent Electric Inc. FFAI

Faraday Future Intelligent Electric Nasdaq/NYSE Compliance Notice

Faraday Future reported that its stockholders' equity of $1.412 million as of June 30, 2026, fell below the Nasdaq minimum requirement of $2.5 million. The company believes it has since regained compliance as of July 31, 2026, through liability reductions, though Nasdaq will continue to monitor the company's status until its next periodic report.

Counterparty
Nasdaq
9:03 AM ET 8-K
Divestiture Surgery Partners, Inc. SGRY

Surgery Partners Divestiture to Intermountain Health for $797M

Surgery Partners, Inc. completed the sale of its ownership interests in Mountain View Hospital and Idaho Falls Community Hospital to Intermountain Health for approximately $796.6 million. The company intends to use the proceeds primarily to pay down existing debt. The transaction closed following the satisfaction of conditions, including physician approvals.

Value
$797M
Counterparty
Intermountain Health
8:31 AM ET 8-K
Clinical Trial Data Telomir Pharmaceuticals, Inc. TELO

Telomir Pharmaceuticals Clinical Trial Data

Telomir Pharmaceuticals announced the publication of peer-reviewed preclinical data in the International Journal of Molecular Sciences demonstrating that Telomir-Zn restored visual function and retinal structure in a model of age-related macular degeneration (AMD). The study showed that 14 days of oral treatment significantly improved visual performance, reduced mitochondrial oxidative stress, and increased telomeric DNA content. While the company remains focused on its Phase 1/2 clinical trial for triple-negative breast cancer, these findings suggest the drug's metal-dependent epigenetic biology may have broader applications beyond oncology.

8:30 AM ET 8-K
M&A Deal Colony Bankcorp Inc CBAN

Colony Bankcorp Signs $163M M&A Deal with First Reliance Bancshares, Inc.

Colony Bankcorp announced it has received all required regulatory approvals for its previously announced $163 million acquisition of First Reliance Bancshares. The merger, which will create a combined institution with approximately $5 billion in assets, is expected to close on November 1, 2026, pending shareholder approvals.

Value
$163M
Counterparty
First Reliance Bancshares, Inc.
8:14 AM ET 8-K
M&A Deal Littelfuse Inc LFUS

Littelfuse M&A Deal with Elmos Semiconductor SE

Littelfuse entered into an amended share purchase and supply agreement with Elmos Semiconductor SE regarding its previously acquired 200mm wafer fab in Dortmund, Germany. The amendment simplifies legacy contractual arrangements and increases strategic flexibility for the asset in exchange for a one-time fee of €24.6 million. This update follows the original acquisition and capacity-sharing arrangement announced in 2023 and 2024.

Counterparty
Elmos Semiconductor SE
Term
through 2029

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.